curriculum vitae - vhir · ann hepatol. 2014 mar-apr;13(2):219-30. immunosuppression based on...

Cristina Dopazo, MD/PhD

Curriculum Vitae

1. Index 1. Index 2 2. Personal Details 3 3. Academic Studies: 4 Primary Medical Qualifications Specialist Medical Qualifications Others 4. Professional Experience: 5

Postgraduate Training Specialist Registration Current Status

5. Academic Activity: 7 Articles Communications 6. Courses and Congresses 37 7. Participation as speaker 45 8. Research Undertaken 47 9. Foreign Units Visited 51 10. Honors and awards 51

3

2. Personal Details

Last Name: Dopazo First Name: Cristina Date of Birth: April 4th, 1977 Address: Passeig Vall ´Hebron 119-129 Zip Code: 08035 City/Province/Country: BARCELONA SPAIN Telephone number: +34932746113 Email address: [email protected] [email protected] Nacionality: Spanish

mailto:[email protected]

mailto:[email protected]

4

3. Academic studies

PRIMARY MEDICAL QUALIFICATION

From September 1995-June 2001: Graduate in Medicine. The duration of the

Spanish medical degree includes six academical years.

Primary Medical Qualification: Medical Bachelor of Medicine

University: Universidad de Santiago de Compostela. A Coruña

Country: Spain. http://www.usc.es

February 2002: MIR TEST (Internal Resident in Medicine). National exam for

getting access to the Spanish Training System

POSTGRADUATE TRAINING

June 2002-June 2007: Postgraduate training as a Resident in General and

Digestive Surgery at the Hospital Vall d´Hebron, Barcelona. http://www.vhebron.es

This period took 5 years, 3 of them as a General Surgeon and the last 2 at the

Hepato-Pancreatico-Biliary and Liver Transplant Unit.

SPECIALIST MEDICAL REGISTRATION

July 2007: Awarded by the Ministry of Education and Culture of Spain (Ministerio de

Educación y Cultura), as a specialist in General and Digestive Tract Surgery.

(Equivalent of CCST).

OTHER IMPORTANT INFORMATION

Presentation of the Doctoral Thesis: Risk factors of late mortality in liver

transplantation. (VIVA on the 7th of February 2007). Duration: 3 years

Score: Cum Laudem

Thesis Director: Dr. Itxarone Bilbao and Dr. Joaquin Balsells

http://www.usc.es/

http://www.vhebron.es/

5

4. Professional Experience

POSTGRADUATE TRAINING

June 2002-June 2007: Resident in General Surgery at the Hospital Vall d´Hebron,

Barcelona. This period took 5 years, 3 of them as a General Surgeon and the last 2

at the Hepato-Pancreatico-Biliary and Liver Transplant Unit.

SPECIALIST REGISTRATION

July 2007- July 2008: Transplant Fellowship at the Department of HPB and

Transplant Surgery, as a Specialist Registrar. Hospital Vall d´Hebron

References: Dr. Ramon Charco (Head of the HPB Department).

Barcelona. Spain

This post also included on call rota (1/5) for General Surgery at the Accident and

Emergency Department, at the Hospital Vall d´Hebron. Reference: Prof. Manel

Armengol

July 2008-August 2009: Locum Consultant in the Department of HPB Surgery and

Transplant, Hospital Vall d´Hebron.

References: Dr. Ramon Charco (Head of the HPB Department)

Barcelona, Spain

CURRENT STATUTS

August 2009 until now: Consultant in the Department of HPB Surgery and

Transplant, Hospital Vall d´Hebron. Main clinical areas of practice are liver and

multivisceral transplantation and all hepato-biliary-pancreas disease. Collaboration

with the Paediatric Liver Trasplant program, including split liver and living donation

(adult to child).

References: Dr. Ramón Charco (Head of the HPB Department)

Barcelona, Spain

6

September 2014 until now: Professor of Universidad Autonoma de Barcelona

(UAB), Department of Surgery.

References: Prof. Manel Armengol

OTHERS

2010-2011 European Universitary Diploma Hepatic-Pancreatic and Biliary

Cancers: Onco-Surgical Strategies

Centre Hepato-Biliaire, Hopital Paul Brousse-Université Paris XI

Director: René Adam

2011 European Board of Surgery Qualification in Transplantation Surgery

(Module1: Multi-organ retrieval; Module 4: Liver Transplantation)

Director: Vassilios Papalois

2012 European Certificate as Personal Investigator for Use Animal on

Experimentation

Barcelona University

Director: Mª Teresa Rodrigo Calduch

7

5. Academic activity MOST RELEVANT ARTICLES Analysis of discarded livers for transplantation.

Escartín A., Castro E., Dopazo C., Bueno J., Bilbao I., Margarit C.

Transplant Proc. 2005; 37(9):3859-60.

Inmunosuppression based on Mycophenolate mofetil in stable liver transplanted patients.

Bilbao I, Castells L, Rojas L, Cancino J, Dopazo C, Castro E, Pou L, Andino R, Margarit C.

Int Inmunopharmacol 2006; 6(13-14): 1977-83.

Análisis de la prueba de compatibilidad entre donantes y receptores y su repercusión en

los resultados del trasplante hepático

Bilbao I, Dopazo C, Castro E, Margarit C.

Med Clin Monogr 2006; 7(5): 18-22.

Angiomiolipoma hepático en dos pacientes con infección por el virus de la hepatitis C.

Bilbao I, Castro E, Dopazo C, Castro S, Allende E, Genesca J, Tallada N, Quiroga S,

Margarit C.

Gastroenterol Hepatol. 2007; 30(4):222-8.

Recurrence of hepatocellular carcinoma after liver transplantation

Escartín A, Sapisochin G, Bilbao I, Vilallonga R, Bueno J, Castells L, Dopazo C, Castro E,

Caralt M, Balsells J.

Transplant Proc. 2007;39 (7):2308-2310.

Leiomiomatosis peritoneal diseminada.

Castro S., Dopazo C., Nadal A., Boqué R., Zanón V., Armengol M.

Cir Esp 2007; 82(2):125-127.

Our experience in liver transplantation in patients over 65yr of age.

Bilbao I, Dopazo C, Lázaro JL, Castells L, Escartín A, López I, Sapisochin G, Balsells J,

Margarit C.

Clin Transplant. 2008;22(1):82-8.

8

Hepatic resection for liver metastases as part of the “oncosurgical” treatment of metastasic

breast cancer

Caralt M, Bilbao I, Cortés J, Escartín A, Lázaro JL, Dopazo C, Olsina JJ, Balsells J, Charco

R.

Ann Surg Oncol. 2008;15 (10):2804-10.

Visceral leishmaniasis among liver transplant recipients: an overview

Campos I, Len O, Castells LL, Tallada N, Ribera E, Dopazo C, Vargas V, Gavaldá J,

Charco R.

Liver Transplant 2008; 14: 1816-1819.

Severe rhabdomyolysis and acute renal failure secondary to concomitant use of

simvastatine and rapamicine in liver transplant patient

Dopazo C, Bilbao I, Lázaro JL, Sapisochin G, Caralt M, Blanco L, Castells l, Charco R

Transplant Proc 2009;41(3):1021-4.

Indications and Management of Everolimus After Liver Transplantation

Bilbao, G. Sapisochin, C. Dopazo, J.L. Lazaro, L. Pou, L. Castells, M. Caralt, L. Blanco, A.

Gantxegi,C. Margarit, R. Charco.

Transplant Proc 2009, 41: 2172–2176.

Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma

recurrence after partial liver resection: experience of a single european series.

Sapisochin G, Bilbao I, Balsells J, Dopazo C, Caralt M, Lázaro JL, Castells L, Allende H,

Charco R.

World J Surg 2010;34 (9):2146-54.

Recidiva del virus de la hepatitis C postrasplante. Tratamiento y regímenes de

inmunosupresión.

Dopazo C, Castells Ll, Bilbao I, Charco R.

Med Clin Mongr 2010; 11 (4): 19-23.

Evolution and management of de novo neoplasm post-liver transplantation: a 20-year

experience from a single European centre.

Sapisochin G, Bilbao I, Dopazo C, Castells L, Lázaro JL, Rodríguez R, Caralt M, Blanco L,

Balsells J, Charco R.

Hepatol Int 2011; 5(2):707-15.

9

Evolution of biliary complications after liver transplantation: a single European series.

Gantxegi A, Caralt M, Bilbao I, Castells L, Lázaro JL, Llopart L, Díez I, Dopazo C,

Sapisochin G, Pérez M. Charco R.

Transplant Proc 2011; 43 (3): 745-8.

Transjugular intrahepatic portosystemic shunt for treatment of sinusoidal obstruction

syndrome in a liver transplant recipient, and review of the literature.

Campos-Varela I, Castells L, Dopazo C, Perez-Lafuente M, Allende H, Len O, Llopart L,

Vargas V, Charco R.

Liver Transpl 2012; 18(2):201-5.

Biliary dilatation and strictures after composite liver-small bowel transplantation in children:

defining a newly recognized complication.

Perera MT, Gupte GL, Sharif K, Hegab B, Dopazo C, Olliff SP, Kelly DA, Muiesan P, Mayer

AD, Mirza DF.

Transplantation 2011; 92(4):461-8.

Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation:

observational multicenter study.

Dopazo C, Rodriguez R, Llado L, Calatayud D, Castells L, Ramos E, Molina V, García R,

Fabregat J, Charco R.

Clin Transplant. 2012; 26(1):E32-7.

Combined liver-intestine grafts compared with isolated intestinal transplantation in children:

a single-center experience.

Dopazo C, Gupte GL, Sharif K, Perera MT, Hartley J, Muiesan P, Mayer DA, Bromley P,

Bennett J, Kelly DA, van Mourik I, McKiernan P, Beath SV, Mirza DF.

Transplantation 2012;94(8):859-65.

Single HCC in Cirrhotic Patients: Liver Resection or Liver Transplantation? Long-term

Outcome According to an Intention-to-treat Basis.

Sapisochin G, Castells L, Dopazo C, Bilbao I, Minguez B, Lázaro JL, Allende H, Balsells J,

Caralt M, Charco R.

Ann Surg Oncol. 2013 Apr;20(4):1194-202.

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Campos-Varela%20I%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Castells%20L%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Dopazo%20C%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Perez-Lafuente%20M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Allende%20H%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Len%20O%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Llopart%20L%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Vargas%20V%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Charco%20R%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Perera%20MT%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gupte%20GL%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sharif%20K%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hegab%20B%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22doPazo%20C%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Olliff%20SP%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kelly%20DA%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Muiesan%20P%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mayer%20AD%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mayer%20AD%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mirza%20DF%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed/23018880




10

Therapeutic management of juxtapapillary duodenal diverticulum.

Beisani M, Espin F, Dopazo C, Quiroga S, Charco R.

Cir Esp. 2013 Aug-Sep;91(7):463-5.

Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric

patients with acute liver failure.

Quintero J, Miserachs M, Ortega J, Bueno J, Dopazo C, Bilbao I, Castells L, Charco R.

Liver Int. 2014 May;34(5):689-94.

Multicentre study on hepatic adenomas.

Ramia JM, Bernardo C, Valdivieso A, Dopazo C, Jover JM, Albiol MT, Pardo F, Fernandez

Aguilar JL, Gutierrez Calvo A, Serrablo A, Diez Valladares L, Pereira F, Sabater L, Muffak

K, Figueras J.

Cir Esp. 2014 Feb;92(2):120-5

Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant

recipients.

Campos-Varela I, Esteban JI, Bes M, Dopazo C, Allende H, Rodríguez-Frías F, Salcedo

MT, Sauleda S, Charco R, Guardia J, Esteban R, Castells L.

Ann Hepatol. 2014 Mar-Apr;13(2):219-30.

Immunosuppression Based on Everolimus in Liver Transplant Recipients With Severe Early

Post-transplantation Neurotoxicity.

Bilbao I, Dopazo C, Castells L, Lazaro J, Caralt M, Sapisochin G, Charco R.

Transplant Proc. 2014;46(9):3104-7.

Multiple indications for everolimus after liver transplantation in current clinical practice.

Bilbao I, Dopazo C, Lazaro J, Castells L, Caralt M, Sapisochin G, Charco R.

World J Transplant. 2014 Jun 24;4(2):122-32

Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and

Analysis of Prognostic Factors for Survival in a Large Euro-American Series.

Sapisochin G, Goldaracena N, Astete S, Laurence JM, Davidson D, Rafael E, Castells L,

Sandroussi C, Bilbao I, Dopazo C, Grant DR, Lázaro JL, Caralt M, Ghanekar A, McGilvray

ID, Lilly L, Cattral MS, Selzner M, Charco R, Greig PD.

Ann Surg Oncol. 2015 Jul;22(7):2286-94












11

Analysis of adult 20-year survivors after liver transplantation

C. Dopazo, I. Bilbao, L. Castells, G. Sapisochin, C. Moreiras , I. Campos-Varela, J.

Echeverri, M. Caralt, J. L. Lázaro, R. Charco

Hepatol Int. 2015 Jul;9(3):461-70

Long-term results of pancreaticoduodenectomy with superior mesenteric and portal vein

resection for ductal adenocarcinoma in the head of the pancreas.

Landi F, Dopazo C, Sapisochin G, Beisani M, Blanco L, Caralt M, Balsells J, Charco R.

Cir Esp. 2015 May 14. pii: S0009-739X(15)00139-6. doi: 10.1016/j.ciresp.2015.04.001.



12

BOOK CHAPTERS

Liver Transplantation: Rejection, Therapy and Post-Operative Complications. Editors:

Kirsten H. Knudsen. Editorial: Nova Science Publishers. 2008. ISBN: 978-1-60456-975-9

Chapter: “Risk factors of Late Mortality Following Liver Transplantation”. Dopazo

C, Bilbao I, Escartín A, Lázaro JL, Caralt M, Balsells J, Charco R.

Immunosuppression: New Research. Editors: Charles B. Taylor. Editorial: Nova Science

Publishers. 2008. ISBN: 978-1-60692-102-9

Chapter: “Indications and manegement of m-TOR inhibitors after liver

transplantation”. Bilbao I, Sapisochin G, Dopazo C, Lázaro JL, Pou L, Castells L,

Caralt M, Gantxegi A, Charco R

Manual sobre el trasplante hepático.

Editors: R. Charco, V. Sánchez, Ll. Castells, V. Cuervas-Mons. Editorial:Euromedice. 2011.

ISBN: 978-84-15134-00-8

Chapter 26 (pag 275-283): "Resultados generales del trasplante hepático: causas

precoces y tardías de fallecimiento y de pérdida del injerto".

I. Bilbao, C. Dopazo, JL Lazaro, Ll. Castells, R. Charco

Neurotoxicidad post-trasplante.

Editors: I. Bilbao, S. Zárraga. Editorial: Profármaco.2. 2014. ISBN: 978-84-88116-55-0

Chapter: “Mielinolisis central pontina asociada a tacrolimus en un paciente

trasplantado hepático”

C. Dopazo

13

MOST RELEVANT COMUNICATIONS

Resección hepática de leiomioma asociado a cistoadenoma biliar en Testigo de Jehová

Dopazo C., Castro S., Aguilar L., Bilbao I., Mas A.*, Allende E.*, Margarit C.

Department of HPB Surgery and Transplants, Hospital Vall d´Hebron (Barcelona)

XIII Course of Cirugía Hepatobiliopancreática y Trasplantes Digestivos. Barcelona,

3-4 June 2003. Oral Communication

IV Congrés Catalá de Cirurgia, Tarrasa 27-28 November 2003. Poster

Communication

Análisis de la morbi-mortalidad a largo plazo en el Trasplante Hepático

Dopazo C., Bilbao I., Solans. A, Lázaro JL., Escartín A., López De Cenarruzabeitia I.,

Bergamini S., Caralt M., Castro E., Margarit C.


XIV Course of Cirugía Hepatobiliopancreática y Trasplantes Digestivos. Barcelona

25 y 26 May 2004. Oral Communication

XXV Congress Nacional de Cirugía, Madrid 9-12 November 2004. Oral

Communication

VIII Congreso de la Societat Catalana de Transplantament, Barcelona 6-9 February

2005. Oral Communication

XVIII Congress of Sociedad Española de Trasplante Hepático (SETH)

Granada, 4-6 October 2006. Poster Communication

Conversión a Mofetil Micofenolato en pacientes trasplantados hepáticos con toxicidad

secundaria a Anticalcineurínicos

Bilbao I., Rojas L., Cancino J., Escartín A., Lázaro JL., Caralt M., Dopazo C., Castro E.,

Margarit C.


XX INTERNATIONAL CONGRESS OF THE TRANSPLANTATION SOCIETY. Viena.

Austria. 5-10 September 2004. Poster Communication

XXV Congress Nacional de Cirugía, Madrid 9-12 November 2004. Oral

Communication

THE 3RD INTERNATIONAL CONGRESS ON IMMUNOSUPPRESSION. San Diego.

USA. 8-11 December 2004. Poster Communication

14

VIII Congreso de la Societat Catalana de Transplantament, Barcelona 6-9 February


12th CONGRESS OF THE EUROPEAN SOCIETY FOR ORGAN

TRANSPLANTATION ESOT 2005. Geneva, 15-19 October 2005. Poster

Communication

7th INTERNATIONAL CONFERENCE ON NEW TRENDS IN

IMMUNOSUPPRESSION AND IMMUNOTHERAPY. Berlin 16-19 February 2006.

Poster Communication

Nuestra experiencia en el trasplante hepático en pacientes mayores de 65 años

Bilbao I., Castells L., Dopazo C., Castro E., Rodríguez R., López I., Escartín A., Bergamini

S., Margarit C.


XXV Congress Nacional de Cirugía. Madrid, 9-12 November 2004. Oral

Communication.

VIII Congress of Societat Catalana de Transplantament. Barcelona, 6-9 February

2005. XVII. Oral Communication

REUNION DE LA SOCIEDAD ESPAÑOLA DE TRASPLANTE HEPÁTICO (SETH).

Barcelona, 5-7 October 2005. Oral Communication

12th CONGRESS OF THE EUROPEAN SOCIETY FOR ORGAN

TRANSPLANTATION. ESOT 2005. Geneva, 15-19 October 2005. Poster

Communication

THE 2006 JOINT INTERNATIONAL GONGRESS OF ILTS, ELITA and LICAGE.

Milan, 3-6 May 2006. Poster Communication.

WORLD TRANSPLANT CONGRESS 2006. THE FIRST JOINT INTERNATIONAL

TRANSPLANT MEETING. Boston 22-27 June, 2006. Oral Communication

7th WORLD CONGRESS OF IHPBA. 10th ANNUAL MEETING OF AUGIS. 3-7

September 2006, Edinburgh, Scotland. Oral Communication.

XXVI CONGRESS NACIONAL DE CIRUGÍA. Madrid, 6-10 November 2006. Oral

Communication

Factores de riesgo de mala evolución en la recurrencia del virus C tras el trasplante hepático

y su relación con la inmunosupresión

A.Solans, I.Bilbao, C.Dopazo, A.Escartin, I.Lopez, S.Bergamini, C.Margarit.


15

THE 3RD INTERNATIONAL CONGRESS ON IMMUNOSUPPRESSION. San Diego.

USA. 8-11 December 2004. Poster Communication.

VIII Congress of Societat Catalana de Transplantament. Barcelona, 6-9 February


7th INTERNATIONAL CONFERENCE ON NEW TRENDS IN

IMMUNOSUPPRESSION AND IMMUNOTHERAPY. Berlin, 16-19 February 2006.

Poster Communication.

IV CONGRESS OF SOCIEDAD ANDALUZA DE TRASPLANTE DE ORGANOS Y

TEJIDOS S.A.T.O.T. Marbella (Malaga), 1-4 March 2006. Oral Communication


Milan, 3-6 May 2006. Poster Communication.

Alternativas a los anticalcineurínicos en la inmunosupresión de mantenimiento

Bilbao I., Dopazo C., Castro E., Pou L., Margarit C.


VIII Congress of Societat Catalana de Transplantament. Barcelona ,6-9 February


Análisis de los injertos hepáticos no válidos

Escartín A., Castro E., Bergamini S., Ruiz-Flores A., Dopazo C., Bueno J., Bilbao I.,

Margarit C.


VIII Congress of Societat Catalana de Transplantament, Barcelona 6-9 February

2005. Poster Communication.

IX CONGRESO NACIONAL DE LA SOCIEDAD MEXICANA Y XVIII CONGRESO

LATINO AMERICANO Y DEL CARIBE DE TRASPLANTES. Mejico. Cancún, 11-15

October 2005. Poster Communication.

Gastrinoma de la ampolla de vater en la Enfermedad de Von Recklinghausen

Rivero J., Dopazo C., Allende E., Olsina JJ., Balsells J., Armengol M.


V Congrés de la Societat Catalana de Cirurgia, Barcelona 5-7 October 2005.


16

Tumor gastrointestinal estromal periampular y yeyunal en Neurofibromatosis tipo 1

Dopazo C., Rivero J., De Torres I., Olsina JJ., Balsells J., Armengol M.


V Congress of Societat Catalana de Cirurgia, Barcelona 5-7 October 2005. Poster

Communication.

Análisis del “matching” entre donantes y receptores y su impacto en los resultados del

trasplante hepático

Bilbao I., Dopazo C., Castro E., Margarit C.


XVII REUNION DE LA SOCIEDAD ESPAÑOLA DE TRASPLANTE HEPÁTICO

(SETH). Barcelona, 5-7 October 2005.Poster Communication.


TEJIDOS S.A.T.O.T. Marbella (Malaga), 1-4 March 2006. Poster Communication.


Milan, 3-6 May 2006.Poster Communication


TRANSPLANT MEETING. Boston, 22-27 July 2006. Poster Communication


September 2006, Edinburgh, Scotland. Poster Communication

CONGRESO NACIONAL DE CIRUGÍA. Madrid, 6-10 November 2006. Oral

Communication

10 años de supervivencia después del trasplante hepático

Bilbao I., Castells L., Dopazo C., Castro E., Rodríguez R., López I., Escartín A., Bergamini

S., Margarit C.


XVII REUNION DE LA SOCIEDAD ESPAÑOLA DE TRASPLANTE HEPÁTICO

(SETH). Barcelona, 5-7 October 2005. Poster Communication


LATINO AMERICANO Y DEL CARIBE DE TRASPLANTES. Cancún, 11-15

October 2005. Poster Communication


TEJIDOS S.A.T.O.T. Marbella (Malaga), 1-4 March 2006. Oral Communication


Milan, 3-6 May 2006. Poster Communication

17


September 2006, Edinburgh, Scotland. Oral Communication

XXVI CONGRESS NACIONAL DE CIRUGÍA. Madrid, 6-10 November 2006. Oral

Communication

Trasplante hepático con donantes mayores de 70 años

Escartín A, Castro E., Dopazo C., Grau S, Bergamini S, Bueno J, Bilbao I, Margarit C



LATINO AMERICANO Y DEL CARIBE DE TRASPLANTES. Mejico. Cancún, 11-15

October 2005. Oral Communication

XV REUNION NACIONAL DE CIRUGÍA. Sevilla, 25-28 October 2005. Oral

Communication

Tumores hepáticos primarios sobre hígado sano

Grau S., Escartín A., Andino R., Castro E., Dopazo C., Bergamini S., Bilbao I., Margarit C.


XV REUNION NACIONAL DE CIRUGÍA. Sevilla, 25-28 October 2005. Oral

Communication

l7th WORLD CONGRESS OF IHPBA. 10th ANNUAL MEETING OF AUGIS. 3-7


Elderly donors could be good liver donors.

Escartín A, Castro E, Bilbao I, Allende H, Dopazo C, Lázaro JL, López I, Balsells J.



TRANSPLANT MEETING. Boston, 22-27 July 2006. Poster Communication

Liver transplantation in HIV-HCV co-infected patients

Alfredo Escartin, Luis Castells, Itxarone Bilbao, Oscar Len, Cristina Dopazo, Ernesto Castro,

Silvina Bergamini, Joaquin Balsells



TRANSPLANT MEETING. Boston, 22-27 July 2006. Oral Communication

18

XVIII CONGRESS OF SOCIEDAD ESPAÑOLA DE TRASPLANTE HEPÁTICO

(SETH). Granada 4-6 October 2006. Poster Communication

9º CONGRESO SOCIETAT CATALANA DE TRASPLANTAMENT. Barcelona, 25-28

February 2007. Oral Communication

Surgery in patients with advanced hepatocellular carcinoma

Escartín A; Grau S; Vilallonga Puy R; Dopazo C; Bueno J; Allende H; Lázaro JL; Bilbao I;

Balsells J.




Surgical treatment of metaststic breast cancer

Caralt M, Escartin A, Bilbao I, Lazaro J, Lopez I, Bergamini S, Dopazo C, Balsells J, Margarit

C.




Patrones de recidiva tras el trasplante hepático por hepatocarcinoma.

Escartín A, Grau S, Vilallonga R, Dopazo C, Castro E, Bergamini S, Bueno J, Bilbao I,

Balsells J.


XVIII Congress of Sociedad Española de Trasplante Hepático. 4-6 October 2006.

Granada. Poster Communication

Hepatocarcinoma y colangiocarcinoma sobre hígados no patológicos. Cirugía hepática.

Vilallonga R, Escartín A, Grau S, Sapisochin G, Castro E, Dopazo C, Bilbao I, Balsells J.


XVIII Jornades de Cirurgia i XI Jornades d’Infermeria de Cirurgia als Hospitals de

Catalunya. 19-20 October 2006. Figueres. Poster Communication

19

Indicaciones y manejo de m-TOR en el trasplante hepático.

Bilbao I, Sapisochin G, Dopazo C, Castro E, Escartín A, Castells L, Lázaro JL, Balsells J.


9º CONGRESS OF SOCIETAT CATALANA DE TRASPLANTAMENT. Barcelona,

25-28 February 2007. Oral Communication

ILTS THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY. 13th

ANNUAL INTERNATIONAL CONGRESS. Rio de Janeiro, Brazil. 20-23 June 2007.


13th Congress of the European Society for Organ Transplantation (ESOT). 29

September-3 October 2007, Praga. Poster Communication

XVI REUNIÓN NACIONAL DE CIRUGÍA. San Sebastián, 23-25 October 2007. Oral

Communication

8th WORLD CONGRESS OF THE INTERNATIONAL HEPATO-PANCREATO-

BILIARY ASOCCIATION (IHPBA). Mumbai, India. 27th February-2nd March 2008.


XXII INTERNATIONAL CONGRESS OF THE TRANSPLANTATION SOCIETY.

Sydney, Australia. 10-14 August 2008. Poster Communication

Situación clínica de los pacientes VHC+ con 10 años de supervivencia.

Bilbao I, Dopazo C, Castells L, Escartín A, Sapisochin G, Castro E, Lázaro Jl, Balsells J.


9º CONGRESS OF SOCIETAT CATALANA DE TRASPLANTAMENT. Barcelona, 25-

28 February 2007. Oral Communication

42nd ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY

OF THE LIVER. Barcelona, 11-15 April 2007. Poster Communication

ILTS THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY. 13th ANNUAL

INTERNATIONAL CONGRESS. Rio de Janeiro, Brazil. 20-23 June 2007. Poster

Communication



XVI REUNIÓN NACIONAL DE CIRUGÍA. San Sebastián, 23-25 October 2007. Oral

Communication

8th WORLD CONGRESSOF THE INTERNATIONAL HEPATO-PANCREATO-

BILIARY ASOCCIATION (IHPBA). Mumbai, India. 27th February-2nd March 2008. Oral

Communication

20

Factores de riesgo de disfunción renal a partir del primer año post-trasplante hepático.

Bilbao I, Dopazo C, Castro E, Sapisochin G, Castells L, Escartín A, Lázaro JL, Balsells J.



28 February 2007. Poster Communication

ILTS THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY. 13th ANNUAL

INTERNATIONAL CONGRESS. Rio de Janeiro, Brazil. 20-23 June 2007. Poster

Communication

XIX CONGRESS OF SOCIEDAD ESPAÑOLA DE TRASPLANTE HEPÁTICO.

Valladolid, 17-19 October 2007. Poster Communication

Factores de riesgo de desarrollar HTA, DM y dislipemia a partir del primer año

postrasplante hepático y su relación con la inmunosupresión.

Dopazo C, Bilbao I, Castro E, Sapisochin G, Castells L, Escartín A, Lázaro JL, Balsells J.



28 February 2007. Poster Communication

Importancia de la situación clínica durante el primer año post-trasplante hepático en la

predicción de supervivencia prolongada.

Dopazo C, Bilbao I, Castro E, Sapisochin G, Castells L, Escartín A, Lázaro JL, Balsells J.


9º CONGRESS OF SOCIETAT CATALANA DE TRASPLANTAMENT. Barcelona,

25-28 February 2007. Poster Communication



Recurrence of hepatocellular carcinoma after liver transplantation.

Castells LL, Escartín A, Vargas V, Sapisochin G, Bilbao I, Bueno J, Dopazo C, Caralt M,

Balsells J.


ILCA´s (International Liver Cancer Association) First Annual Conference. 5-7

October 2007. Barcelona. Poster Communication

21

Outcome of liver transplantation for hepatitis C in Haemophilic patients coinfectated with

VIH.

Sapisochin G, Escartín A, Bilbao I, Castells LL, Dopazo C, Lázaro JL, Altisent C, Balsells J.




XIX CONGRESO DE LA SOCIEDAD ESPAÑOLA DE TRASPLANTE HEPÁTICO.





Guillain-Barré Syndrome after liver transplantation: a case report.

Bilbao I, Sapisochin G, Viladot M, Len O, Dopazo C, Vargas V, Castells LL, Lázaro JL,

Balsells J.






The Novo Malignancies after liver transplantation.

Bilbao I, Sapisochin G, Dopazo C, Lázaro JL, Castells LL, Balsells J.



BILIARY ASOCCIATION (IHPBA). Mumbai, India. 27th February-2nd March 2008. Oral

Communication


Sydney, Australia. 10-14 August 2008. Poster Communication

Hepatectomies for non-malignant and non-infectious liver masses.

Sapisochin G, Dopazo C, Bilbao I, Escartín A, Lázaro Jl, Balsells J.


22




Fibrolamellar hepatocellular carcinoma and large focal nodular hyperplasia: a case report an

review of the literature.

Sapisochin G, Dopazo C, Escartín A, Lázaro JL, Bilbao I, Balsells J.





Krukenberg´s tumor as a first manifestation of fibrolamellar hepatocarcinoma.

Bilbao I, Vilallonga R, Dopazo C, Allende E, Viladomiu Ll, Quiroga S, Margarit C.





Graft versus host after liver transplantation

Bilbao I, Dopazo C, Len O, Castells Ll, Lázaro Jl, López I, Escartín A, Sapisochin G,

Balsells J





XX Congress of Sociedad Española de Trasplante Hepático (SETH).Oviedo, 8-10

October 2008. Poster communication

Management of pancreatic neuroendocrine tumors: a single center experience

Olsina JJ, Sapisochin G, Dopazo C, Ganchegui A, Caralt M, Escartín A, Naval J, Lázaro JL,

Bilbao I, Balsells J


23




Liver Surgery and management of neuroendocrine hepatic metastases

Sapisochin G, Bilbao I, Escartín A, Dopazo C, Lázaro JL, Olsina JJ, Balsells J


8th WORLD CONGRES SOF THE INTERNATIONAL HEPATO-PANCREATO-



Use of liver grafts from donors older than 70 years in recipients with chronic HCV

Charco R, Escartín A, Lázaro JL, Bilbao I, Allende H, Dopazo C, Caralt M, Castells LL



Sydney, Australia. 10-14 August 2008. Oral communication.

Long-term outcome of patients who underwent liver transplantation for HCC with previous

liver resection.

Sapisochin G, Dopazo C, Gantxegi A, Caralt M, Blanco L, Lázaro JL, Bilbao I, Castells L,

Allende H, Balsells J , Charco R.



October 2008. Oral communication.

XXVII Congress Nacional de Cirugía. Madrid, 3-6 November 2008. Oral

communication.

10th Congress of Societat Catalana de Trasplantament, Barcelona, 22-25 February

2009. Oral communication.

15th Annual International Congress International Liver Transplantation Society (ILTS),

New York, 8-11 July 2009. Poster communication

14th Congress of the European Society for Organ Transplantation (ESOT). Paris, 30

Aug- 2 Sep 2009. Oral Communication

24

Papel del everolimus como inmunosupresor principal en el postoperatorio inmediato del

trasplante hepático.

Bilbao I, Dopazo C, Sapisochin G, Lázaro JL, Castells L, Caralt M, Gantxegi A, Charco R.



October 2008.Poster communication.


2009. Poster communication.

Indicaciones y manejo de everolimus en el trasplante hepático.

Bilbao I, Sapisochin G, Dopazo C, Lázaro Jl, Castells L, Caralt M, Gantxegi A, Pou L, Charco

R.



October 2008. Poster communication.

10th Congress of Societat Catalana de Trasplantament, Barcelona, 22-25 ofFebruary

2009. Poster comunication.

Complicaciones neurológicas tras el trasplante hepático.

Bilbao I, Dopazo C, Lázaro Jl, Castells L, Sapisochin G, Caralt M, Gantxegi A, Charco R.


October 2008. Poster comunication.


2009. Poster comunication.

Rabdomiolisis y fallo renal agudo secundario a la administración concomitante de rapamicina

y estatinas en trasplantado hepático.

Dopazo C, Bilbao I, Sapisochin G, Lázaro Jl, Escartín A, Caralt M, Charco R


XX Congress Sociedad Española de Trasplante Hepático (SETH).Oviedo, 8-10


One thousand liver transplantation from a single center

Caralt M, Escartín A, Bueno J, Lázaro JL, Bilbao I, Dopazo C, Sapisochin G, Charco R.

25




XXVII Congreso Nacional de Cirugía. Madrid, 3-6 November 2008. Oral

communication.

10th Congress of Societat Catalana de Trasplantament, Barcelona, 22-25 of February


VIII Congress of the European Hepato-Pancreato Biliary Association (IHPBA), Atenas,

18-20 June 2009. Oral communication


Aug-2 Sept 2009. Poster communication

Evolution and Management of De Novo Neoplasms post-liver transplantation. A 20 year

experience from a single European center

Sapisochin G, Bilbao I, Dopazo C, Castells L, Blanco L, Caralt M, Lázaro JL, Balsells J y

Charco R.





communication.



9th World Congress of the International Hepato-Pancreato-Biliary Association

(IHPBA), Buenos Aires, 18-22 April 2010. Poster communication

16th Annual International Congress, International Liver Transplantation Society,

Hong Kong, 16-19 June 2010. Poster communication

XXIII International Congress of the Transplantation Society, Vancouver, 15-19

August 2010. Poster communication

Long term outcome of hepatic resection for noncolorectal nonneuroendocrine liver

metastases.

Sapisochin G, Dopazo C, Bilbao I, Caralt M, Blanco L, Lázaro JL, Olsina J, Balsells J, Charco

R.


26


communication.

VIII Congress of the European Hepato-Pancreato Biliary Association (IHPBA), Athens,

18-20 June 2009. Poster communication

Are repeat liver resections a safe and effective treatment for recurrent colorectal liver

metastases?

Dopazo C, Bilbao I, Sapisochin G, Rodríguez R, Gantxegi A, Blanco L, Caralt M, Lázaro JL,



XXVII Congress Nacional de Cirugía. Madrid, 3-6 of November 2008. Oral

communication.

VIII Congress of the European Hepato-Pancreato Biliary Association (IHPBA), Athens,

18-20 June 2009. Poster communication.

Evolution and results of liver retransplantation in a 20 years period

Bilbao I, Dopazo C, Lázaro JL, Castells L, Sapisochin G, Caralt M, Blanco L, Gantxegi A,

Margarit C, Charco R




15th Annual International Congress International Liver Transplantation Society

(ILTS), New York, 8-11 July 2009. Poster communication.

XXI Congress of Sociedad Española de Trasplante hepático. Badajoz, 7-9 October


Impacto de una lista única para pacientes priorizados en el trasplante hepático por

hepatocarcinoma

Gantxegi A, Sapisochin G, Castells L, Bilbao I, Lázaro JL, Dopazo C, Caralt M, Blanco L,





27

Virus de la Hepatitis B y Trasplante Hepático. Experiencia de 20 años

Campos-Varela I, Castells L, Vargas V, Rodríguez-Frias F, Bilbao I, Dopazo C, Buti M,

Charco R, Esteban R, Guardia J.


XXXIV Congress of Asociación Española para el Estudio del Hígado. Madrid, 25-27

February 2009. Oral communication

De impact of Diabetes Mellitus in long-term outcome of liver transplant patients for hepatitis C

Dopazo C, Bilbao I, Sapisochin G, Castells L, Lázaro JL, Blando I, Caralt M, Rodríguez R,

Charco R.



Aug-2 Sept 2009. Poster communication

20 years evolution of HCV liver transplanted patients, according to inmunosupression

Bilbao I, Castells Ll, Dopazo C, Allende H, Lázaro JL, Caralt M, Blanco L, Charco R.


15th Annual International Congress International Liver Transplantation Society

(ILTS), New York, 8-11 July 2009. Oral communication.

XXI Congress of Sociedad Española de Trasplante hepático. Badajoz, 7-9 October


Actualización y recomendaciones para la utilización de drenajes en Cirugía Abdominal

Ganxegui A, Lázaro JL, Naval J, Baena JA, Gander R, Rodríguez R, Sapisochin G, Dopazo

C, Caralt M, Bilbao I, Charco R.


XVII Reunión Nacional de Cirugía. Palmas de Gran Canaria, 21-24 October 2009.

Poster communication.

28

Role of liver resection in successful long-term survival of patients with cancers developing

late hepatic metastasis

Caralt M, Martí J, Bilbao I, Sapisochin G, Rodríguez R, Blanco L, Dopazo C, Lázaro JL,

Fuster J, Fondevila C, García-Valdecasas JC, Charco R.

Department of HPB Surgery and Transplants, Hospital Vall d´Hebron (Barcelona) and

Hospital Clinic (Barcelona)


(IHPBA), Buenos Aires, 18-22 April 2010. Oral communication

Evolution of biliary complications after liver transplantation. 20 years experience from a

single European series.

Caralt M, Gantxegi A, Rodríguez R, Alvarez L, Bilbao I, Lázaro JL, Dopazo C, Blanco L,

Sapisochin G, Castells Ll, Charco R.






Aplication of BCLC staging system for patients with hepatocellular carcinoma (HCC) before

1999. Does it affect prognosis?

Sapisochin G, Bilbao I, Dopazo C, Fernández de Sevilla E, Caralt M, Blanco L, Rodríguez

R, Castells Ll, Lázaro JL, Balsells J, Charco R.







Agosto 2010. Poster communication

Long-term outcome of patients with intermediate hepatocellular carcinoma. Where is the

role of liver resection?

Sapisochin G, Dopazo C, Fernández de Sevilla E, Rodríguez R, Blanco L, Caralt M,

Castells Ll, Allende H, Balsells J, Bilbao I, Charco R.

29




Analysis of metabolic changes at reperfusion in children undergoing intestinal

transplantation

Dopazo C, Taha A, Gupte G, Sharif K, Hartley J, Muiesan P, Mayer D, Bromley P, Bennet

J, Mirza DF.

Liver Unit, Birmingham Children´s Hospital (UK)


August 2010. Poster communication

Risk factors for early mortality following intestinal transplantation in children. Multivariate

analysis.

Dopazo C, Taha A, Gupte G, Sharif K, Hartley J, Muiesan P, Mayer D, Bromley P, Bennet

J, Mirza DF.

Liver Unit, Birmingham Children´s Hospital (UK)


August 2010. Oral communication

TTS XII International Small Bowel Transplant Symposium, Washington 15-18

September 2011. Oral communication

Conversión from Prograf to Advagraf in Liver Transplant. Observational Multicenter study

Dopazo C, Rodríguez R, Lladó L, Calatayud D, Castells Ll, Ramos E, Molina V, García R,

Fabregat J, Charco R.

Department of HPB Surgery and Transplants, Hospital Vall d´Hebron (Barcelona), Hospital

de Bellvitge (Barcelona) and Hospital Clinic (Barcelona)

XI Congress of Societat Catalana Catalana de Transplantament. Barcelona,

16-18 March 2011. Poster communication.

16th Joint International Congress of ILTS, ELITA & LICAGE, Valencia, 22-25

June 2011. Poster communication.

15th Congress of the European Society for Organ Transplantation and 22nd

Annual BSHI Conference. 4-7 September 20011, Glasgow, UK. Oral

communication.

30

Estado actual de pacientes trasplantados hepáticos en edad pediàtrica con más de 20

años de seguimiento.


Gander R, Bueno J, Quintero J, Legarda M, Ortega J, Bilbao I, Castells Ll, Martínez-Ibañez

V, Dopazo C, Charco R.


16-18 March 2011. Oral communication

Impacto de la priorización MELD en el Hospital Vall d´Hebron, un centro de lista espera

corta

Bilbao I, Espín F, Dopazo C, Castells L, Lázaro JL, Rodríguez R, Sapisochin G, Gantxegi

A, Charco R.



16-18 March 2011. Oral communication

Everolimus un inmunosupresor con múltiples indicaciones en trasplante hepático

Bilbao I, Dopazo C, Sapisochin G, Lázaro JL, Castells Ll, Rodríguez R, Espín F, Gantxegi

A, Charco R.



16-18 March 2011. Poster communication


June 2011. Poster communication

XXIII Congress of Sociedad Española de Trasplante Hepático, Bilbao, 5-7


2º Congress of Sociedad Española de Trasplante, Madrid, 23-26 June 2012.

Poster communication

Post-transplant long term management of patients with pre liver transplantation renal

insufficiency

Bilbao I, Dopazo C, Castells Ll, Lázaro JL, Rodríguez R, Espín F, Charco R.


2011 Joint International Congress of ILTS, ELITA & LICAGE, Valencia, 22-

25 June 2011. Poster communication

31



24th International Congress of the Transplantation Society, Berlín, 15-19

July 2012. Poster communication

The impact of everolimus based immunosuppression on HCV recurrence after liver

transplantation: case-control study.

Dopazo C, Bilbao I, Espín F, Castells Ll, Sapisochin G, Campos-Varela I, Rodríguez R,

Caralt M, Lázaro JL, Charco R.



June 2011. Poster communication


Annual BSHI Conference. 4-7 September 20011, Glasgow, UK. Oral

communication.

Does late recurrence after hepatectomy for HCC impact on survival after liver

transplantation for HCC recurrence? A case report.

Sapisochin G, Dopazo C, Rodríguez R, Espín F, Castells Ll, Caralt M, Lázaro JL, Bilbao I.



Annual BSHI Conference. 4-7 September 20011, Glasgow, UK. Poster

communication

¿Debe la diferenciación tumoral excluir pacientes con hepatocarcinoma del trasplante

hepático en una era de escasez de donantes?

Sapisochin G, Dopazo C, Rodríguez R, Bilbao I, Castells l, Campos I, Lázaro JL, Allende

H, Caralt M, R Charco.



October 2011. Oral communication

Colangiocarcinoma intrahepático en pacientes trasplantados hepáticos por

hepatocarcinoma. ¿Se debería incluir como indicación de trasplante hepático?

Sapisochin G, Asencio JM, Dopazo C, Rodríguez R, Bilbao I, Castells l, Campos I, Lázaro

JL, Caralt M, Allende H, Charco R.


32


October 2011. Oral communication

Nuestra experiencia en el donante vivo para trasplante hepático infantil

Bilbao I, Dopazo C, Lázaro JL, Rodríguez R, Bueno J, Charco R.




Tumores neuroendocrinos pancreáticos

Blanco L, Rodríguez R, Dopazo C, Sapisochin G, Balsells J, Olsina J, Naval J, Charco R.


XVIII Reunión Nacional de Cirugía, Pamplona, 9-11 November 2011. Poster

communication

Early and late indications of everolimus after liver transplantaion

Bilbao I, Dopazo C, Lázaro JL, Sapisochin G, Castells Ll, Rodríguez R, Guevara A, Charco

R.


47th Annual meeting of the European Association for the Study of the Liver,

Barcelona, 18-22 April 2012. Poster communication

24th International Congress of the Transplantation Society, Berlín, 15-19 July

2012. Poster communication

Long-term outcome of cirrhotic patients with single HCC ≤ 5cm. Does liver resection have

the same results as liver transplantation?

Sapisochin G, Dopazo C, Bilbao I, Castells Ll, Lázaro JL, Mínguez B, Campos-Varela I,

Rodríguez R, Caralt M, Charco R.


47th Annual meeting of the European Association for the Study of the Liver,

Barcelona, 18-22 April 2012. Poster communication

17th Annual International Congress of the International Transplantation

Society, San Francisco (CA), 16-19 May 2012. Oral communication

Long-term Outcome of liver transplant patients who develop “De Novo” solid tumors.

Standard Oncological strategies may cure our patients.

33

Sapisochin G, Landi F, Bilbao I, Dopazo C, Castells Ll, Rodríguez R, Campos I, Lázaro JL,

Caralt M, Charco R.



Society, San Francisco (CA), 16-19 May 2012. Poster communication

Obesity and metabolic syndrome along 15 years after liver transplanted patients.

Bilbao I, Guevara A, Dopazo C, Castells Ll, Lázaro JL, Rodríguez R, Sapisochin G,

Campos-Varela I, Charco R.




2º Congress of Sociedad Española de Trasplante, Madrid, 23-26 June 2012.

Oral communication


2012. Poster communication

Long-Term outcome of HCV liver transplanted patients according to immunosuppression

with cyclosporine or tacrolimus.

Bilbao I, Castells Ll, Dopazo C, Lázaro JL, Rodríguez R, Sapisochin G, Charco R.




Long-term follow-up and risk factors associated with “De Novo” solid tumors after adult liver

transplantation.

Sapisochin G, Bilbao I, Landi F, Dopazo C, Castells Ll, Rodríguez R, Campos I, Lázaro JL,

Torres M, Caralt M, Charco R




Tratamiento con peg-interferón y ribavirina durante la fase aguda de la recurrencia de la

hepatitis C vs tratamiento diferido tras trasplante hepático.

Campos-Varela I, Esteban JL, Dopazo C, Bes M, Rodríguez-Frías F, Allende H, Bilbao I,

Esteban R, Castells Ll.

Department of HPB Surgery and Transplants. Liver Unit, Internal Medicine.

VHIR.CIBEREHD. Hospital Vall d´Hebron (Barcelona)

34

2º Congress of Sociedad Española de Trasplante, Madrid, 23-26 Junio 2012.

Oral communication

Multicentre Study of Liver Cell Adenomas

Ramia JM, Bernardo C, Valdivieso A, Dopazo C, Jover JM, Figueras J, Pardo F,

Fernández-Aguilar JL.

Liver Units from: Hospital de Guadalajara, Hospital Central de Asturias, Hospital de Cruces

(Bilbao), Hospital Vall d´Hebron (Barcelona), Hospital de Getafe (Madrid), Hospital Josep

Trueta (Girona), Hospital Clinica de Navarra (Pamplona), Hospital Carlos Haya (Málaga)

10th World Congress of the International Hepato-Pancreato-Biliary

Association, Paris, 1-5 July 2012. Oral communication

Potencial Antifibrotic effect of Long-Term Everolimus based Immunosuppression in HCV

positive liver transplant patients.

Dopazo C, Bilbao I, Castells Ll, Sapisochin G, Campos-Varela I, Lázaro JL, Caralt M,

Charco R.



2012. Oral communication

Influencia de la anastomosis duodenoyeyunal antecólica versus trasmesocólica en el

retraso del vaciamento gástrico post-duodenopancreatectomía cefálica con preservación

pilórica

Beisani M, Dopazo C, Blanco L, Caralt M. Sapisochin G, Landi F, Fernández de Sevilla E,

Naval J, Olsina JJ, Balsells J, Charco R.


29th National Congress of Surgery. Madrid, 12-15 November 2012.Oral

communication

Resultados a largo plazo de la pancreatectomía con resección venosa mesentérico-portal

en el cancer de pancreas localmente avanzado: experiencia del Hospital Universitario Vall

d´Hebron.

Landi F, Blanco L, Dopazo C, Sapisochin G, Caralt M, Beisani M, Torres M, Salgado R,

Naval J, Balsells J, Charco R.


35

29º National Congress of Surgery. Madrid, 12-15 November 2012. Oral

communication

A case of acute humoral rejection as cause of acute liver failure one year after liver

transplant

C. Dopazo, I Bilbao, Ll Castells, G Vellalta, G Sapisochin, M Caralt, JL Lázaro, R Charco


16th Congress of the European Society for Organ Transplantation. Viena, 8-

11 September 2013. Oral communication

Benefit of treating HCC recurrence after liver transplantation

G Sapisochin, S Astete, I Bilbao, C Dopazo, JL Lázaro, B Mínguez, Ll Castells, M Caralt,

R Charco


16th Congress of the European Society for Organ Transplantation. Viena, 8-

11 September 2013. Oral communication

Analysis of adult 20-year survivors after liver transplantation

C. Dopazo, I Bilbao, C Moreiras, G Sapisochin, L Castells, M Caralt, JL Lázaro, R Charco


XXIV Congress of the Sociedad Española de Trasplante Hepático (SETH).

Córdoba, 2-4 October 2013. Poster

ILTS 2014 Joint International Congress of ILTS, ELITA & LICAGE, London

June 4-7 2014. Poster

Inmunosupresión basada en Everolimus en casos de neurotoxicidad en el post-operatorio

precoz del trasplante hepático.

I Bilbao, C. Dopazo, JL Lázaro, , L Castells, M Caralt, G Sapisochin, S De La Serna, R

Charco


XXIV Congress of the Sociedad Española de Trasplante Hepático (SETH).

Córdoba, 2-4 October 2013. Poster

The impact of body mass Index in the long term outcome of liver transplanted patients.

I Bilbao, L Castells, C. Dopazo, JL Lázaro, ,M Caralt, S De La Serna, C Moreira, R Charco


36


4-7 June 2014. Poster

III Congreso de la Sociedad Española de Trasplante (SET). Valencia, 8-10

June 2014. Oral Communication

Where is the máximum benefit of everolimus after liver transplantation: early or late

indication.

I Bilbao, L Castells, C. Dopazo, JL Lázaro, ,M Caralt, S De La Serna, C Moreira, R Charco



4-7 June 2014. Poster

III Congreso de la Sociedad Española de Trasplante (SET). Valencia, 8-10

June 2014. Oral Communication

Ventajas del abordaje endoscópico transgástrico en el tratamiento de las complicaciones

graves de la pancreatitis aguda

C. Dopazo, J Balsells, M Abu-Suboh, L Blanco, M Caralt, S De La Serna, JR Armengol, R

Charco


30º Congreso Nacional de Cirugía, Madrid 11-13 November 2014. Oral

Communication

37

6. Attendance at courses and congresses

XIII Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation

Hospital Vall d`Hebrón

Barcelona, 3-4 June 2003

Direction: C. Margarit

VII National Course on Organ Transplantation

Zaragoza, 28-30 April 2004

XIV Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation


Barcelona, 25-26 May 2004


VIII Congress of Societat Catalana de Trasplantament

Barcelona, 6-9 February 2005

XV Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation




XII Congress of the European Society for Organ Transplantation (ESOT)

Ginebra, 15-19 October 2005

IV International meeting on Living donor liver and Kidney Transplantation

Barcelona, 14-15 November 2005

IV Congress of Sociedad Andaluza de Trasplante de Organos y Tejidos (SATOT).

Marbella, 3-4 March 2006

38

XVI Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation


Barcelona, 2-3 May 2006.

Direction: J. Balsells, I. Bilbao

The 2006 Joint Internacional Congress of ILTS, ELITA and LICAGE

Milán, 3-6 May 2006

XVIII Congress of Sociedad Española de Trasplante Hepático (SETH)

Granada, 4-6 October 2006

XI Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation for Residents

in General and Digestive Surgery of 5th year.

Pamplona, 23-25 October 2006

Direction: F. Pardo

The Hesperis Course. Course on Transplantology under guide of European Collage of

Transplantation, held in Lyon (October 2006) and in Malmo (May 2007)

Direction: European Society Organ Transplantation

References: J Lloveras

IX Congress of Societat Catalana de Trasplantament


V Workshop on Liver Metastases from Colorectal Cancer Surgery

Girona, 28 February 2007

Direction: J. Figueras

XVII Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation

Hospital Vall d`Hebron


Direction: J. Balsells, I. Bilbao

39

XIII Congress of the European Society for Organ Transplantation (ESOT)

Praga, 30 September-3 October 2007

V International Meeting on Living Donor Liver and Kidney Transplantation


III Hispano-French Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation

Valencia, 11-13 March 2008

Direction: Dr. Casanova, Dr. Santoyo, Dr. Delpero, Dr. Belghiti

II Course on Liver Surgery

Barcelona, 26 - 27 May 2008

Liver Surgery and Transplant Unit. Institut Clinic de Enfermedades Digestivas y

Metabólicas y el Institut d´Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS) del

Hospital Clinic.

Direction: JC García Valdecasas

XVIII Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation

Barcelona, 10 -11 June 2008. Hospital Vall d´Hebrón

. Direction: R. Charco

The 2008 Joint international Congress of ILTS, ELITA & LICAGE

París, 9-12 July 2008

9th European Transplant Fellow Workshop of ESOT

Padova, 19-21 September 2008

Direction: RJ. Porte, P. Burra, RJ. Ploeg

XX Congress of Sociedad Española de Trasplante Hepático (SETH)

Oviedo, 8-19 October 2008

2nd International NOTES WIDER (Natural Orifice Transluminal Endoscopic Surgery)


Direction: JR Armengol-Miró, M Armengol Carrasco, AJ Torres

40

10th CONGRESS OF SOCIETAT CATALANA DE TRANSPLANTAMENT.


IX Workshop on Liver Metastases from Colorectal Cancer Surgery

Barcelona, 3 April 2009

Direction: J. Figueras

IV Hispano-French Course on Hepato-Pancreato-Biliary Surgery and Organ

Transplantation

Lyon, 21-23 April 2009

Direction: Jacques Baulieux

XIX Course on Hepato-Pancreato-Biliary Surgery and Organ Transplantation

Hospital Vall d´Hebron


Direction: R. Charco

VI Reunión Nuevas Artes (Novartis)

Baiona, 8-9 June 2009.

Direction: R. Charco, J. Meneu

Organ Retrieval Workshop

Birmingham, 3-4 November 2009

Direction: Mr. Darius Mirza

2nd Evidence in Transplantation Course

London, 12-13 March 2010

11 European CME (Continuing Medical Education) credits

Direction: Prof. Morris, Mr. J. Forsythe, Dr. J. Van der Meulen

41

1st Birmingham Children's Hospital in Clinical Ultrasonography

Birmingham, 16-17 July 2010

14 CDP (Continuing Professional Development) points

Direction: Dr. Dinesh Rawat

UK Liver Surgeons Training Course

Basingstoke (UK) y Elancourt (France), 18-20 July 2010

11 CDP points

Direction: Mr. David Berry, Prof. John Buckels, Mr. Timothy John, Mr. Neil Pearce, Mr.

Raj Prasad, Prof. John Primrose, Mr. Myrdin Rees

XXIII International Congress of The Transplantation Society

Vancouver, 15-19 August 2010

32.50 hours

XI Congress Societat Catalana de Transplantament

Barcelona, 16-18 March 2001

V Course of Cirugía Hepática Avanzada

Unidad de Cirugía Hepática y Trasplante. Institut Clinic de Enfermedades Digestivas y

metabólicas y el Institut d´Investigacions Biomediques Agustí Pi i Sunyer (IDIBAPS) del

Hospital Clinic de Barcelona


17 hours

2011 Joint International Congress of ILTS, ELITA & LICAGE

Valencia, 22-25 June 2011

23 hours

15th Congress of the European Society for Organ Transplantation

Glasgow, 4-7 September 2011

TTS XII International Small Bowel Transplant Symposium

42

Washington, 15-18 September 2011

24 hours

III International Workshop on the Treatment of Hepatic and Lung Metastases of Colorectal

Carcinoma


11 ESMO_MORA points

Preceptorship Liver Transplant Course

Liver Unit Hospital Clinic, Barcelona

15-16 March 2012

10 hours

Director: M. Navasa

I Simposio Multidisciplinar Estrategias Onco-Quirúrgicas en el Area Hepato-Bilio-

Pancreática.

Málaga, 19-20 April 2012

1.5 credits

Director: J. Santoyo

VI Curso de Cirugía Hepática Avanzada

Unidad de Cirugía Hepática y Trasplante. Institut Clinic de Enfermedades Digestivas y

metabólicas y el Institut d´Investigacions Biomediques Agustí Pi i Sunyer (IDIBAPS) del

Hospital Clinic de Barcelona


2.8 credits

Director: JC. Valdecasas

II Congreso de la Sociedad de Trasplante

Madrid, 23-26 June 2012

3.7 credits

43

24th International Congress of The Transplantation Society

Berlín, 14-19 July 2012

24 hours, AMA PRA Category 1 Credits

4th ELITA Split-Liver Course. ELITA-LICAGE Liver Meeting

Ghent, 13-15 September 2012

360 Degrees in liver metastases from colorectal cancer. How to build a performing

multidisciplinary team. Serono Symposia International

Rome, 9-10 November 2012

9 hours, AMA PRA Category 1 Credits

Director: R. Adam

IX Curso CIVITAS 2012 de Inmunología y Virología en Trasplantes

Madrid, 16 November 2012

Director: JM. Aguado

Jornadas de Otoño Trasplante Hepático


Director: M. Navasa

12º Congreso de la Sociedad Catalana de Transplantament

Barcelona, 13-15 March 2013

1,34 crédits

Liver Transplantation PreceptorShip

Hospital Paul Brousse,

París, 6-7 May 2013

Director: F. Saliba

44

II VINCIT. Update Virus Inmunosupresión y Complicaciones Infecciosas en Trasplante

Madrid, 14 June 2013

1,1 créditos

Director: JM Aguado

16th Congreso de la European Society for Organ Transplantation

Viena, 8-11 Septiembre 2013

2013 PreceptorShip in Oncology

Hospital Paul Brousse

París, 7-10 Octubre 2013

Director: R. Adam

4th International Workshop on the treatment of hepatic and lung metastases of colorectal

carcinoma

Barcelona, 14-15 Noviembre 2013

Director: Ll Cirera

I Curso Práctico de Formación Continuada en Cirugía HBP

Girona, 5-8 May 2014

4,3 credits

2014 Joint International Congress of ILTS, ELITA & LiCAGE

London, 4-7 Juneo 2014

22 horas, AMA PRA Category 1 Credits

Course of Laparoscopic Liver Surgery

Centro de Cirugía Mínima Invasiva “Jesús Usón” Cáceres

Cáceres, 23-24 October 2014

45

7.Participation as speaker

Metástasis sincrónicas. ¿Cirugía en un tiempo?

XVIII Course of Cirugía Hepatobiliopancreática y Trasplantes

Servicio de Cirugía HBP y Trasplantes del H. Vall d´Hebrón.

Barcelona, 11 June 2008.

2.4 Credits

Recidiva del VHC. Tratamiento e inmunosupresión.

VI Reunión Nuevas Artes

Baiona, 8 June 2009

Alternatives to whole liver donation and donation after brain death

1st Joint Israeli-Catalan Transplant Symposium

Tel Aviv, 5 December 2010

Experiencia y resultados del tratamiento quirúrgico de los tumores quísticos de

páncreas

Sociedad Catalana de Cirugía


Diagnosis and multi-disciplinary management of liver metastases from gastrointestinal

stromal tumour (GIST)

53º Regional Congress of Sociedad Siciliana de Cirugía

Portorosa, 12-14 May 2011

Efecto características donante vivo. Edad

VIII Edición de Nuevas Artes

Córdoba, 16-17 May 2011

Aspectos logísticos y técnicos del Split

XIII Fórum de Cirujanos de Trasplante Hepático

Málaga, 8-9 March 2012

3.1 credits

46

Risk Factors for severe ischemia-reperfusion injury after liver transplant in the era of

“bad donors”

4th ELITA Split-Liver Course

Ghent, 13 September 2012

Surgical approach to liver metastases

Update Course on Gastrointestinal Cancer Managament

Hospital Vall d´Hebron

Barcelona

15 February 2013

26 February 2013

20 September 2013

13 June 2014

Ventajas del abordaje transgástrico en el tratamiento de las complicaciones graves de

la pancreatitis aguda

Sociedad Catalana de Cirugía


New Surgical Horizonts in the Approach of Metastatic Colorectal Cancer

HOPE 2014(6th Edition): From Genetics to therapeutic advances that transform lives

Cascais (Portugal), 1 November 2014

47

8. Reseach undertaken

PK-STUDY IN DE NOVO LTX PATIENTS: A STUDY TO INVESTIGATE THE PHARMACOKINETICS OF TACROLIMUS (FK 506) MODIFIED RELEASE CAPSULES (MR-4) IN PATIENTS UNDERGOING PRIMARY LIVER TRANSPLANTATION. (FG-506-11-XX-01).A LONG-TERM FOLLOW-UP STUDY TO EVALUATE THE SAFETY AND EFFICACY IN TRANSPLANT RECIPIENTS TREATED WITH MODIFIED RELEASE TACROLIMUS, FK 506E (MR4), BASED IMMUNOSUPPRESSION REGIMEN” (FG-506-14-02)

Investigator: Dr. C.Margarit. Co-investigators: Dra.I.Bilbao, Dra Dopazo Financiation : Fujisawa GMBH. Duration : 2002-03

ESTUDIO MULTICÉNTRICO, RANDOMIZADO, DOBLE CIEGO, COMPARATIVO CON UNA PAUTA DOBLE CON TACROLIMUS, EN GRUPOS PARALELOS, CON DOSIS MÚLTIPLES POR VÍA ORAL QUE EVALÚA LA SEGURIDAD, TOLERABILIDAD, EFICACIA Y FARMACOCINÉTICA DE FK 778 EN PACIENTES TRASPLANTADOS HEPÁTICOS QUE RECIBEN UN TRATAMIENTO HABITUAL CON ESTEROIDES Y TACROLIMUS (FK 506).

Investigator : Dr.C.Margarit. Co-investigator: Dr.I.Bilbao, E.Hidalgo, JL Lazaro, L.Pou, E.Murio, C Dopazo, L.Castells, E.Allende. Duration : 2002- 2003

ESTUDIO MULTICENTRICO 1:1, RANDOMIZADO, DOBLE CIEGO, CON 2 BRAZOS PARALELOS, PARA EVALUAR Y COMPARAR LA EFICACIA Y SEGURIDAD DE TACROLIMUS FK 506 VERSUS TACROLIMUS DE LIBERACIÓN RETARDADA, FK 506E (MR4), EN COMBINACIÓN CON ESTEROIDES, EN PACIENTES SOMETIDOS A TRASPLANTE HEPÁTICO PRIMARIO

Investigator : Dr.Margarit Co-investigator : Dra. I.Bilbao, C.Dopazo, L.Pou Duration: 2004-2005

ESTUDIO ALEATORIZADO, ABIERTO, CON GRUPOS PARALELOS PARA COMPARAR SANDIMMUN NEORAL (Ciclosporina) CON MONITORIZACION A LAS 2 HORAS POST-DOSIS CON TACROLIMUS CON MONITORIZACION VALLE, EN PACIENTES TRASPLANTADOS HEPATICOS DE NOVO (versión 04.07.2003)”. Codigo de protocolo NEOTACRO-C2. Código hospital AC(HG)112/2003 (1394).

Investigator : Dr.Margarit / Dra Bilbao Co-investigator : Dra. I.Bilbao, C. Dopazo Duration : 2004-2006

ESTUDIO SOBRE LA TERAPIA PREVENTIVA (PROFILAXIS) CON GANCICLOVIR INTRAVENOSO CONTRA LA ENFERMEDAD POR CITOMEGALOVIRUS EN PACIENTES INMUNOCOMPROMETIDOS TRAS UN TRASPLANTE DE ORGANO (RIÑON, HIGADO, CORAZON Y PULMON). ESTUDIO ECOVAL. Patrocinator Roche SA.

Investigator: Dra I Bilbao Co-investigator : Dra. Dopazo Duration: June-August 2003

48

AN OPEN, RANDOMISED, MULTICENTRE, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF TACROLIMUS AND MINIMAL STEROIDS IN COMBINATION WITH EITHER A MONOCLONAL ANTI-IL2R ANTIBODY (DACLIZUMAB) OR MYCOPHENOLATE MOFETIL IN LIVER ALLOGRAFT TRANSPLANTATION. (MARSILEA, Phase III, FG 506-01-27)

Investigator : Dra. Itxarone BILBAO Co-investigators : Dr.Escartin, Dr.Lopez, Dra.Bergamini, Dra. Dopazo, Dra. Pou, Dra. Allende y Dr. Margarit Duration : 2005-2006.

ESTUDIO RESCUE: CERTICAN EN RECEPTORES DE TRASPLANTE HEPÁTICO CON INSUFICIENCIA RENAL (RAD001). Estudio multicentrico, aleatorizado, abierto, de 6 meses de seguimiento, sobre la seguridad y la eficacia de un régimen basado en everolimus (Certican) frente a un régimen basado en ICN, en pacientes receptores de trasplante hepático en mantenimiento. Protocol Number : CRAD001H2401

INVESTIGATOR : Dra Itxarone BILBAO Co-investigator : Dra. Dopazo, Dra Pou

Duration : 2006-2007 Promotor : Novartis

SILVER TRIAL: A PROSPECTIVE RANDOMIZED, OPEN-LABELED TRIAL COMPARING SIROLIMUS-CONTAINING VERSUS mTOR-INHIBITOR-FREE IMMUNOSUPPRESSION IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA. Regensburg University (Germany)

Protocol Number EudraCT : 2005-005362-36. INVESTIGATOR: Dra Itxarone BILBAO Co-investigator : C.Dopazo.

Duration: 2006-2013

ESTUDIO ABIERTO , ALEATORIZADO, MULTICENTRICO, NACIONAL, PARA COMPARAR EL RIESGO DE ENFERMEDAD CARDIOVASCULAR EN PACIENTES ADULTOS RECEPTORES DE UN PRIMER ALOINJERTO HEPÁTICO, TRATADOS CON UN REGIMEN LIBRE DE ESTEROIDES (TACROLIMUS CON MICOFENOLATO MOFETIL) FRENTE A UN REGIMEN CONVENCIONAL (TACROLIMUS CON ESTEROIDES).

Codigo Rhytmo Protocol Number EudraCT: 2005-000786-19. . INVESTIGATOR: Dra Itxarone Bilbao Co-investigators: Dr Margarit, Dra Dopazo, Dra L Pou Promotor: Instituto Científico Tecnológico de Navarra

Duration: 2006-2007 ESTUDIO PROSPECTIVO PARA EVALUAR LA PREVALENCIA Y RELEVANCIA CLÍNICA DE LOS POLIMORFISMOS EN LOS GENES CODIFICADORES DE ENZIMAS DE BIOTRANSFORMACIÓN Y PROTEINAS TRANSPORTADORAS DE TACROLIMUS Y MOFETIL MICOFENOLATO. Estudio Livergen INVESTIGATOR: Dra. Itxarone Bilbao

49

Co-investigators: Dr. Balsells, Dra. Pou, Dra. Dopazo Promotor: Sociedad Andaluza de Trasplantes de Organos y Tejidos (SATOT) Duration: 2007-2010

ESTUDIO MULTICÉNTRICO PARA EVALUAR LA EFECTIVIDAD Y SEGURIDAD DE TACROLIMUS DE LIBERACIÓN PROLONGADA EN COMBINACIÓN CON ESTEROIDES EN PACIENTES RECEPTORES DE UN PRIMER TRASPLANTE HEPATICO. Estudio Chartac INVESTIGATOR: Dr. Charco Co-investigators: Dra. Bilbao. Dra. Caralt, Dra. Dopazo, Dra. Blanco Duration: 2008- 2010 A RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIVABIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS EudraCT Number 2007-004729-16 INVESTIGATOR: Dr. Len, Dra Bilbao Co-investigator: Dra. Dopazo Duration: 2008-2009 ESTUDIO UNICÉNTRO, PILOTO, PROSPECTIVO, ABIERTO, NO CONTROLADO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE UNA INMUNOSUPRESIÓN DE BAJA NEFROTOXICIDAD, BASADA EN LA UTILIZACIÓN DE ATeGe-FRESENIUS, EN PACIENTES CON INSUFICIENCIA RENAL PRETRASPLANTE HEPÁTICO” Code: ATG-IRA.HVH.10 EudraCT Number: 2011-000691-34 ClinicalTrail.gov: NCT01453218 INVESTIGATOR: Dra. Bilbao Co-investigator: Dra. Dopazo Duration: 2011-2013 SEGUIMIENTO PERSONALIZADO DE LOS PACIENTES TRASPLANTADOS HEPÁTICOS INFECTADOS POR EL VIRUS DE LA HEPATITIS C. ESTUDIO PILOTO PARA COMPARAR LA EVOLUCIÓN DE LA HEPATITIS C, SEGÚN RECIBAN INMUNOSUPRESIÓN CON TACROLIMUS EN COMBINACIÓN CON MICOFENOLATO MOFETIL O EVEROLIMUS Code: EVL-VHC-HVH.12 Eudra CT Number: 2011-000691-34 ClinicalTrial.gov: NCT01707849 INVESTIGATOR: Dra. Bilbao Co-Investigator: Dra. Dopazo Duration: 2012-2015 VALOR PREDICTIVO DEL FLUJO VASCULAR PORTAL Y ARTERIAL DE LA LESIÓN ISQUEMIA-REPERFUSIÓN EN TRASPLANTE HEPÁTICO. EFECTO BUFFER Code: FV-I/R.TH2012 Prospective observational study approved by Ethical Committee on 04.12.2012 INVESTIGATOR: Dr. Charco Co-investigator: Dra. Dopazo Duration: 2013-2015

50

'ESTUDIO DE FASE 2, ALEATORIZADO, DE BÚSQUEDA DE DOSIS PARA EVALUAR LA SEGURIDAD Y LA ACTIVIDAD ANTICITOMEGALOVIRUS (CMV) DE MARIBAVIR FRENTE A VALGANCICLOVIR PARA EL TRATAMIENTO DE INFECCIONES POR CMV EN RECEPTORES DE TRASPLANTES SIN ENFERMEDAD ORGÁN ICA POR CMV.' EudraCT number: 2010-024247-32

INVESTIGATOR:Dr. Oscar Len

Co-Investigator: Dra. Dopazo

Duration: 2013-2015 ESTUDIO MULTICÉNTRICO, ALEATORIZADO, ABIERTO, CONTROLADO, DE 12 MESES DE SEGUIMIENTO PARA EVALUAR EL IMPACTO EN LA FUNCIÓN RENAL DE UN RÉGIMEN INMUNOSUPRESOR BASADO EN LA MINIMIZACIÓN DE TACROLIMUS EN ASOCIACIÓN CON EVEROLIMUS EN PACIENTES RECEPTORES DE UN TRASPLANTE HEPÁTICO DE NOVO. ESTUDIO REDUCE Code: CRAD001HES01 EudraCT Number: 2013-001191-38

INVESTIGATOR: Dr. Charco Torra Co-Investigator: Dra. Dopazo

Duration: 2013-2015 APLICACIÓN DE LA TECNOLOGÍA DE SECUENCIACIÓN MASIVA PARA OPTIMIZAR EL COSTE-EFECTIVIDAD DEL TRATAMIENTO DE LA HEPATITIC C (VHC) EN LA ERA DE LOS INHIBIDORES DE ACCIÓN DIRECTA (DAAs). National Grant (Beca FIS 2013). Expediente PI13/00456 INVESTIGATOR: Dr. Esteban Mur Co-investigator: Dr. Quer, Dr.Castells, Dra. Dopazo

Duration: 2013-2015 HUMAN MICROBIOTA AND LIVER TRANSPLANT Code: MICROTA.TRASHEP.13 Prospective observational study approved by Ethical Committee on 24/01/2014 Clinical Trial NCT02223468 INVESTIGATORL: Dra. Bilbao Co-investigator: C. Dopazo Duration: 2014- 2016

51

9. Foreign Units Visited (Highlights) 1st April-30th June 2007: Rotation in Children´s Hospital of Pittsburgh, Division of Pediatric

Transplant Surgery, directed by George Mazariegos.

27th July 2009-1st August 2010: Rotation in Queen Elizabeth and Children´s Hospital in

Birmingham, Division of HPB Surgery and Transplant, directed by Mr. Darius Mirza.

10. Honors and Awards

Scholar ship from “Asociación Española de Cirujanos” for travelling and training in liver

transplantation in Children´s Hospital of Pittsburgh (April-June 2007).

Scholar ship from “Fundación Mútua Madrileña” for travelling and training in liver

transplantation in Queen Elizabeth Hospital, Birmingham (August 2009-August 2010).

III CONGRESS OF SOCIEDAD ANDALUZA DE TRASPLANTE DE ORGANOS Y TEJIDOS

S.A.T.O.T. Marbella (Malaga), 1-4 March 2006.

“Situación clínica de los pacientes 10 años después del trasplante hepático”.

Bilbao I, Dopazo C, Castells L, Castro E, Escartin A, Lopez I, Bergamini S, Margarit C.

Award to the “best oral communication” of the Congress.

9th CONGRESS OF SOCIETAT CATALANA DE TRASPLANTAMENT. Barcelona, 25-28

February 2007.

“Situacion clinica de pacientes trasplantados hepáticos VHC (+) con 10 años de

supervivencia”. I Bilbao, C Dopazo, L Castells, A Escartin, G Sapisochin, E Castro, JL

Lazaro, J Balsells.

Award to the “best poster communication” of the Congress.

10th CONGRESS OF SOCIETAT CATALANA DE TRANSPLANTAMENT. Barcelona, 22-25

February 2009

“Seguimiento a largo plazo de pacientes con trasplante hepático por recidiva del

hepatocarcinoma previamente resecado. Estudio caso-control.”

52

Sapisochin G, Bilbao I, Dopazo C, Lázaro JL, Castells L, Caralt M, Balsells J y

Charco R.

Award to the “best oral communication” of the Congress.

AWARD TO THE BEST ARTICLE PUBLISHED IN 2013. Societat Catalana de

Transplantament

Single HCC in Cirrhotic Patients: Liver Resection or Liver Transplantation? Long-

term Outcome According to an Intention-to-treat Basis.

Sapisochin G, Castells L, Dopazo C, Bilbao I, Minguez B, Lázaro JL, Allende H,

Balsells J, Caralt M, Charco R. Ann Surg Oncol. 2013 Apr;20(4):1194-202



curriculum vitae - vhir · ann hepatol. 2014 mar-apr;13(2):219-30. immunosuppression based on...

Documents